AI and Cancer Research ── 2026-11-21

New papers on cancer and AI, collected from journal feeds, PubMed (searched across all journals) and OpenAlex (a public index used instead of Google Scholar), judged by Jev (an AI that makes language judgements): original research, AI central, which of 13 themes, treatment or trials, and then ranked by importance up to a daily limit. Journals are not filtered by impact factor; each paper shows its journal's IF-equivalent (OpenAlex two-year mean citedness) and the date of that value. Each entry shows the full original abstract.
All cancers: Cancer biology(0)
Hematologic malignancies: AML(0) · CML(0) · ALL(0) · CLL(0) · Lymphoma(0) · Myeloma(0)
Solid tumors: Breast(0) · Lung(0) · Colorectal(1) · Pancreatic(0) · Prostate(0) · Brain(0) · Ovarian(0) · Endometrial(0) · Gastric(0) · Liver(0) · Kidney(0) · Bladder(0)
Rare cancers: ACC(0)
Cancer molecular biology and AI
No new qualifying paper for this issue.
Hematologic malignancies
Acute myeloid leukemia (AML): treatment, trials and AI
No new qualifying paper for this issue.
Chronic myeloid leukemia (CML): treatment, trials and AI
No new qualifying paper for this issue.
Acute lymphoblastic leukemia (ALL): treatment, trials and AI
No new qualifying paper for this issue.
Chronic lymphocytic leukemia (CLL): treatment, trials and AI
No new qualifying paper for this issue.
Lymphoma: treatment, trials and AI
No new qualifying paper for this issue.
Multiple myeloma: treatment, trials and AI
No new qualifying paper for this issue.
Solid tumors
Breast cancer: treatment, trials and AI
No new qualifying paper for this issue.
Lung cancer: treatment, trials and AI
No new qualifying paper for this issue.
Colorectal cancer: screening, treatment, trials and AI
- Abstract
npj Digital Medicine, Published online: 19 November 2026; doi:10.1038/s41746-026-03434-3 Multicenter evaluation of radiomics and multimodal artificial intelligence for colorectal cancer diagnosis and survival prediction
Journal IF-equivalent: 18.6 (OpenAlex 2-year mean citedness, value as of 2026-11-13, retrieved 2026-11-15; not the official Clarivate IF)Reference: Cao Y, Wu K, Ying J, Li R, Zhou J, Ding Q, et al. Multicenter evaluation of radiomics and multimodal artificial intelligence for colorectal cancer diagnosis and survival prediction. npj Digit Med. 2026 Nov 19 [Epub ahead of print]. doi:10.1038/s41746-026-03434-3.Checked: Abstract only
Pancreatic cancer: treatment, trials and AI
No new qualifying paper for this issue.
Prostate cancer: treatment, trials and AI
No new qualifying paper for this issue.
Brain tumours: treatment, trials and AI
No new qualifying paper for this issue.
Ovarian cancer: treatment, trials and AI
No new qualifying paper for this issue.
Endometrial cancer: treatment, trials and AI
No new qualifying paper for this issue.
Gastric cancer: treatment, trials and AI
No new qualifying paper for this issue.
Liver cancer: treatment, trials and AI
No new qualifying paper for this issue.
Kidney cancer: treatment, trials and AI
No new qualifying paper for this issue.
Bladder cancer: treatment, trials and AI
No new qualifying paper for this issue.
Rare cancers
Adenoid cystic carcinoma: treatment, trials and AI
No new qualifying paper for this issue.